Caraco Warning Letter Calls Into Question Company’s Expansion Plans

Drug Industry Daily
A A
The FDA released a warning letter citing Caraco Pharmaceutical Laboratories for alleged current good manufacturing practice (cGMP) violations Tuesday, calling into question the company’s expansion plans for its Detroit manufacturing facility.

To View This Article:

Login

Subscribe To Drug Industry Daily